Comparing Bictegravir / Emtricitabine / Tenofovir Alafenamide vs Genvoya
| Bictegravir / emtricitabine / tenofovir alafenamide | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|---|
| Bictegravir / emtricitabine / tenofovir alafenamide | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for HIV Infection. Bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Prescription only
Genvoya is a combination antiviral medication that also includes a pharmacokinetic enhancer that can be used to treat people and children with HIV-1 who meet certain criteria. It is 84% to 93%... View more |
||||||||
| More about Bictegravir / emtricitabine / tenofovir alafenamide | More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) | ||||||||
| Ratings & Reviews | |||||||||
|
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.2 out of 10 from a total of 229 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 19% reported a negative effect. |
Genvoya has an average rating of 7.2 out of 10 from a total of 129 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Bictegravir / emtricitabine / tenofovir alafenamide side effects |
View all Genvoya side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Genvoya prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Biktarvy |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
180 hours |
17 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 446 drugs are known to interact with Bictegravir / emtricitabine / tenofovir alafenamide:
|
A total of 710 drugs are known to interact with Genvoya:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
February 07, 2018 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.